H.R. 796 · 119th Congress (2025–2027)
Second Chance for Moms Act
This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Show official title
To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 796’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Mary E. Miller (R-IL-15)
- Cosponsors
13 cosponsors
9 original · 4 later
13 R
- Rep. Brian Babin (R-TX-36)· Original · Jan 28, 2025
- Rep. Andrew S. Clyde (R-GA-9)· Original · Jan 28, 2025
- Rep. Andy Harris (R-MD-1)· Original · Jan 28, 2025
- Rep. Barry Moore (R-AL-1)· Original · Jan 28, 2025
- Rep. Riley M. Moore (R-WV-2)· Original · Jan 28, 2025
- Rep. Andrew Ogles (R-TN-5)· Original · Jan 28, 2025
- Rep. Claudia Tenney (R-NY-24)· Original · Jan 28, 2025
- Rep. Daniel Webster (R-FL-11)· Original · Jan 28, 2025
- Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Jan 28, 2025
- Rep. Mark Harris (R-NC-8)· Later · Feb 4, 2025
- Rep. Gary J. Palmer (R-AL-6)· Later · Feb 6, 2025
- Rep. John W. Rose (R-TN-6)· Later · Feb 26, 2025
- Rep. Sheri Biggs (R-SC-3)· Later · Apr 1, 2025
- Policy area
- Health
- Subjects
- Abortion
- Consumer affairs
- Prescription drugs
- Sex and reproductive health
- Telephone and wireless communication
- Women's health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Second Chance for Moms Act
Display title, Short title · Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.
Official title · Introduced in House